Document is current

Any future updates will be listed below

Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting

Crossref DOI link: https://doi.org/10.1007/s00415-025-13107-y

Published Online: 2025-06-04

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark